Clinical Study

Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir

Table 3

Areas under the curve according to significant contributing factors for viral response.

Factors AUC95% CI

ALT0.7610.0340.561–0.961
Percentage reduction of HBs Ag at week 120.8480.0050.687–1.000
Percentage reduction of HBs Ag at week 160.8330.0070.687–1.000

AUC, area under the curve; CI, confidential interval; ALT, alanine aminotransferase; HBs Ag, hepatitis B antigen.